Systemic Insulin-like Growth Factor-1 Reverses Hypoalgesia and Improves Mobility in a Mouse Model of Diabetic Peripheral Neuropathy.

MLA

Chu, Qiuming, et al. “Systemic Insulin-like Growth Factor-1 Reverses Hypoalgesia and Improves Mobility in a Mouse Model of Diabetic Peripheral Neuropathy.” Molecular Therapy, vol. 16, no. 8, Aug. 2008, pp. 1400–08. EBSCOhost, https://doi.org/10.1038/mt.2008.115.

APA

Chu, Q., Moreland, R., Yew, N. S., Foley, J., Ziegler, R., & Scheule, R. K. (2008). Systemic Insulin-like Growth Factor-1 Reverses Hypoalgesia and Improves Mobility in a Mouse Model of Diabetic Peripheral Neuropathy. Molecular Therapy, 16(8), 1400–1408. https://doi.org/10.1038/mt.2008.115

Chicago

Chu, Qiuming, Rod Moreland, Nelson S Yew, Joseph Foley, Robin Ziegler, and Ronald K Scheule. 2008. “Systemic Insulin-like Growth Factor-1 Reverses Hypoalgesia and Improves Mobility in a Mouse Model of Diabetic Peripheral Neuropathy.” Molecular Therapy 16 (8): 1400–1408. doi:10.1038/mt.2008.115.